Company Filing History:
Years Active: 1986-1991
Title: **Gilbert Corneille: Innovating Pharmaceutical Formulations**
Introduction
Gilbert Corneille is a notable inventor based in Paris, France, recognized for his significant contributions to the field of pharmaceutical formulations. With three patents to his name, Corneille’s work reflects his dedication to advancing the efficacy and delivery of medicaments.
Latest Patents
Corneille’s latest innovations focus on processes for preparing delayed action and programmed release pharmaceuticals. One key patent introduces processes aimed at developing delayed action galenic forms, where the application solutions of excipients, coatings, and active constituents are tailored to a specific pH. This technique enhances the independence of the dissolution rate of controlled release oral pharmaceutical forms by incorporating pH adjusting agents with every application solution.
Additionally, he has developed a new pharmaceutical form for oral use that includes delayed action and controlled absorption medicaments. This invention features an association of miniaturized granules, which are obtained through high to very high compression. These granules are enriched with pH control agents, coated with excipients that slow the penetration of digestive liquids, and may even incorporate a very thin layer of lipids. This advancement also includes granules containing glucose and varying solubility pH control agents, resulting in innovative pH gradient miniaturized granules.
Career Highlights
Corneille is currently affiliated with Elan Corporation, Plc, a company known for its commitment to innovative healthcare solutions. His work within the organization has propelled him to the forefront of pharmaceutical research and development, showcasing his expertise and innovative spirit.
Collaborations
Throughout his career, Gilbert Corneille has collaborated with notable figures in the pharmaceutical industry, including his coworker Donald E Panoz. Together, they have contributed to groundbreaking advancements that enhance the delivery systems of medications, demonstrating the importance of teamwork in the innovation process.
Conclusion
Gilbert Corneille continues to influence the pharmaceutical industry with his innovative approaches to drug formulation. His patents not only improve the effectiveness of medicaments but also set a benchmark for future developments in the field. As he advances his work with Elan Corporation, the impact of his contributions will undoubtedly resonate within the industry for years to come.